ACS Medicinal Chemistry Letters, Journal Year: 2025, Volume and Issue: 16(4), P. 538 - 539
Published: April 1, 2025
Provided herein are novel compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such in treating asthma or COPD, and processes for preparing compounds.
Language: Английский
ACS Medicinal Chemistry Letters, Journal Year: 2025, Volume and Issue: 16(4), P. 538 - 539
Published: April 1, 2025
Provided herein are novel compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such in treating asthma or COPD, and processes for preparing compounds.
Language: Английский
Citations
0